[1]
|
LAUNER LJ,BERGER K,BRETELER MM,et al.Regional variability in the prevalence of cerebral white matter lesions:an MRI study in 9 European countries (CASCADE)[J].Neuroepidemiology,2006,26(1):23. |
[2]
|
WEN W,SACHDEV PS,LI JJ,et al.White matter hyperintensities in the forties:their prevalence and topography in an epidemiological sample aged 44-48[J].Hum Brain Mapp,2009,30(4):1155. |
[3]
|
POGGESI A,PANTONI L,INZITARI D,et al.2001-2011:a decade of the LADIS(Leukoaraiosis And DISability) study:what have we Learned about white matter changes and small-vessel disease?[J].Cerebrovasc Dis,2011,32(6):577. |
[4]
|
ALBERTI KGMM,ZIMMET P,SHAW J.The metabolic syndrome-a new worldwide definition[J].The Lancet,2005,366(9491):1059. |
[5]
|
CORNIER MA,DABELEA D,HERNANDEZ TL,et al.The metabolic syndrome[J].Endocr Rev,2008,29(7):777. |
[6]
|
GU D,REYNOLDS K,WU X,et al.Prevalence of the metabolic syndrome and overweight among adults in China[J].Lancet,2005,365(9468):1398. |
[7]
|
PARK K,YASUDA N,TOYONAGA S,et al.Significant association between leukoaraiosis and metabolic syndrome in healthy subjects[J].Neurology,2007,69(10):974. |
[8]
|
GRUNDY SM,CLEEMAN JI,DANIELS SR,et al.Diagnosis and management of the metabolic syndrome:an American Heart Association/National Heart,Lung,and Blood Institute Scientific Statement[J].Circulation,2005,112(17):2735. |
[9]
|
ALBERTI KGMM,ZIMMET P,SHAW J.The metabolic syndrome-a new worldwide definition[J].The Lancet,2005,366(9491):1059. |
[10]
|
FAZEKAS F,CHAWLUK JB,ALAVI A,et al.MR signal abnormalities at 1.5 T in Alzheimer's dementia and normal aging[J].Am J Roentgenol,1987,149(2):351. |
[11]
|
PANTONI L,BASILE AM,PRACUCCI G,et al.Impact of age-related cerebral white matter changes on the transition to disability-the LADIS study:rationale,design and methodology[J].Neuroepidemiology,2005,24(1/2):51. |
[12]
|
CHOBANIAN AV,BAKRIS GL,BLACK HR,et al.The Seventh Report of the Joint National Committee on Prevention,Detection,Evaluation,and Treatment of High Blood Pressure:the JNC 7 report[J].JAMA,2003,289(19):2560. |
[13]
|
ALBERTI KG,ZIMMET PZ.Definition,diagnosis and classification of diabetes mellitus and its complications.Part 1:diagnosis and classification of diabetes mellitus provisional report of a WHO consultation[J].Diabet Med,1998,15(7):539. |
[14]
|
FORD ES,GILES WH,DIETZ WH.Prevalence of the metabolic syndrome among US adults:findings from the third National Health and Nutrition Examination Survey[J].JAMA,2002,287(3):356. |
[15]
|
MAGGI S,NOALE M,GALLINA P,et al.Metabolic syndrome,diabetes,and cardiovascular disease in an elderly Caucasian cohort:the Italian Longitudinal Study on Aging[J].J Gerontol A Biol Sci Med Sci,2006,61(5):505. |
[16]
|
WANG J,LI H,FRANCO OH,et al.Adiponectin and metabolic syndrome in middle-aged and elderly Chinese[J].Obesity (Silver Spring),2008,16(1):172. |
[17]
|
FARKAS E,DE VOS RA,DONKA G,et al.Age-related microvascular degeneration in the human cerebral periventricular white matter[J].Acta Neuropathol,2006,111(2):150. |
[18]
|
GREGOR MF,HOTAMISLIGIL GS.Inflammatory mechanisms in obesity[J].Annu Rev Immunol,2011,29:415. |
[19]
|
PURKAYASTHA S,CAI D.Neuroinflammatory basis of metabolic syndrome[J].Mol Metab,2013,2(4):356. |
[20]
|
FORNAGE M,CHIANG YA,O'MEARA ES,et al.Biomarkers of Inflammation and MRI-Defined Small Vessel Disease of the Brain:The Cardiovascular Health Study[J].Stroke,2008,39(7):1952. |
[21]
|
BAYTURAN O,TUZCU EM,LAVOIE A,et al.The metabolic syndrome,its component risk factors,and progression of coronary atherosclerosis[J].Arch Intern Med,2010,170(5):478. |